Literature DB >> 21176406

Effects of acute cytomegalovirus infection on rat islet allograft survival.

M J Smelt1, B J de Haan, M M Faas, B N Melgert, A de Haan, P de Vos.   

Abstract

Transplantation of pancreatic islets is a promising therapy for the treatment of type 1 diabetes mellitus. However, long-term islet graft survival rates are still unsatisfactory low. In this study we investigated the role of cytomegalovirus (CMV) in islet allograft failure. STZ-diabetic rats received an allogenic islet graft in combination with either an acute CMV infection or control infection. A third group received ganciclovir treatment in addition to the CMV infection. Graft function was assessed by measuring basal blood glucose levels. After sacrifice, the islet grafts were retrieved for analysis of infection and leukocyte infiltration. CMV-infected recipients demonstrated accelerated islet graft failure compared to noninfected controls. CMV infection of the graft was only observed prior to complete graft failure. Quantification of the leukocyte infiltration demonstrated increased CD8(+) T-cell and NK cell infiltration in the CMV-infected grafts compared to the controls. This suggests that CMV infection accelerates immune-mediated graft destruction. Antiviral ganciclovir treatment did not prevent accelerated graft failure, despite effectively decreasing the grade of infection. Our data confirm the recently published CITR data, which state that CMV is an independent risk factor for failure of islet grafts. Also, our data demonstrate that new approaches for preventing virus-induced islet allograft failure may be required.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21176406     DOI: 10.3727/096368910X545077

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  3 in total

1.  Belatacept and sirolimus prolong nonhuman primate islet allograft survival: adverse consequences of concomitant alefacept therapy.

Authors:  M C Lowe; I R Badell; A P Turner; P W Thompson; F V Leopardi; E A Strobert; C P Larsen; A D Kirk
Journal:  Am J Transplant       Date:  2012-12-27       Impact factor: 8.086

2.  The Efficacy of a Prevascularized, Retrievable Poly(D,L,-lactide-co-ε-caprolactone) Subcutaneous Scaffold as Transplantation Site for Pancreatic Islets.

Authors:  Alexandra M Smink; Shiri Li; Don T Hertsig; Bart J de Haan; Leendert Schwab; Aart A van Apeldoorn; Eelco de Koning; Marijke M Faas; Jonathan R T Lakey; Paul de Vos
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

3.  Stimulation of vascularization of a subcutaneous scaffold applicable for pancreatic islet-transplantation enhances immediate post-transplant islet graft function but not long-term normoglycemia.

Authors:  Alexandra M Smink; Shiri Li; Daniël H Swart; Don T Hertsig; Bart J de Haan; Jan A A M Kamps; Leendert Schwab; Aart A van Apeldoorn; Eelco de Koning; Marijke M Faas; Jonathan R T Lakey; Paul de Vos
Journal:  J Biomed Mater Res A       Date:  2017-06-15       Impact factor: 4.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.